Chronic inflammation is a hallmark of atherosclerosis, with various immune mediators (such as chemokines and lipids) and inflammatory signaling pathways (including MAPK, PI3K, JAK/STAT, and NF-κB) identified as targets for CVD [80,81]. This evidence concerns the gene NFKB1 and atherosclerosis.